The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Oct. 25, 2022
Filed:
Jan. 06, 2017
Applicant:
Fujimori Kogyo Co., Ltd., Tokyo, JP;
Inventors:
Kazuya Hosokawa, Tokyo, JP;
Tomoko Wada, Tokyo, JP;
Hisayo Kaneko, Tokyo, JP;
Takaaki Hasegawa, Tokyo, JP;
Tomoka Nagasato, Tokyo, JP;
Assignee:
FUJIMORI KOGYO CO., LTD., Tokyo, JP;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
G01N 33/49 (2006.01); G01N 33/86 (2006.01); A61B 5/15 (2006.01); G01N 33/48 (2006.01); C12Q 1/34 (2006.01); A61B 5/154 (2006.01); G01N 11/16 (2006.01); C12N 9/99 (2006.01);
U.S. Cl.
CPC ...
G01N 33/4905 (2013.01); A61B 5/15003 (2013.01); A61B 5/154 (2013.01); A61B 5/150755 (2013.01); C12Q 1/34 (2013.01); G01N 11/16 (2013.01); G01N 33/48 (2013.01); G01N 33/86 (2013.01); A61B 5/150351 (2013.01); C12N 9/99 (2013.01); G01N 2333/7454 (2013.01); G01N 2333/8117 (2013.01); G01N 2333/96455 (2013.01); G01N 2333/96458 (2013.01);
Abstract
A method for analyzing thrombogenic capacity or blood coagulation capacity, the method comprising adding calcium, a blood coagulation factor XII (FXII) inhibitor, and a kallikrein inhibitor to blood collected with a blood collection tube containing sodium citrate, to allow initiation of blood coagulation reaction, is provided. Preferably, heparin, heparan sulfate, and tissue factor are further added to the blood, and thrombogenic capacity or blood coagulation capacity is analyzed.